Gefitinib API Market
Gefitinib API Market Scope: Industry Analysis,
Market Size, Growth, Trends Till 2031
Request Sample Report
Gefitinib API Market Size and Growth
The Gefitinib API market is experiencing significant growth, driven by increasing cancer incidence and demand for targeted therapies. The global market size is projected to reach approximately $450 million by 2025, with a compound annual growth rate of around 7%. Competitive pricing and regulatory approvals are crucial in shaping market dynamics.
Companies Covered
(Covid 19 Impact Covered)
◍ Scion Pharm Taiwan
◍ Farmhispania Group
◍ Chem Genix
◍ Jeil Pharmaceutical
◍ Zhuhai Rundu Pharma
◍ Cipla
◍ Brawn Laboratories
◍ Nischem International
◍ Zhejiang Hisun Pharmaceutical
◍ Qilu Pharmaceutial
The Gefitinib API market features companies like Scion Pharm Taiwan and Cipla, which produce and supply gefitinib for cancer treatment. These firms enhance market growth through innovation, production capacities, and strategic partnerships. Key players have achieved notable sales revenues, contributing to an expanding therapeutic landscape.
Request Sample Report
Market Segmentation
By Application
Gefitinib Tablets
Other
Request Sample Report
By Product
Purity ≥ 98 %
Purity ≥ 99 %
Market Growth
Request Sample Report
$ X Billion USD
